Approval · Notice of Compliance 19362 · 2017
SALIX: Notice of Compliance 19362
Issued May 26, 2017
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 19362
- Date
- May 26, 2017
- Company
- Intervet Canada CorpKirkland, Quebec, Canada
- Product type
- Veterinary
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Manufacturing changes
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SALIX | 00116238 | Marketed |
Medicinal ingredients
- FUROSEMIDE 50 MG per ML